...
首页> 外文期刊>BMC Medical Genomics >Clinical, genomics and networking analyses of a high-altitude native American Ecuadorian patient with congenital insensitivity to pain with anhidrosis: a case report
【24h】

Clinical, genomics and networking analyses of a high-altitude native American Ecuadorian patient with congenital insensitivity to pain with anhidrosis: a case report

机译:高原原生美洲厄瓜尼亚患者的临床,基因组学和网络分析,以先天性对嗜睡的疼痛:案例报告

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Congenital insensitivity to pain with anhidrosis (CIPA) is an extremely rare autosomal recessive disorder characterized by insensitivity to pain, inability to sweat and intellectual disability. CIPA is caused by mutations in the neurotrophic tyrosine kinase receptor type 1 gene (NTRK1) that encodes the high-affinity receptor of nerve growth factor (NGF). Here, we present clinical and molecular findings in a 9-year-old girl with CIPA. The high-altitude indigenous Ecuadorian patient presented several health problems such as anhidrosis, bone fractures, self-mutilation, osteochondroma, intellectual disability and Riga-Fede disease. After the mutational analysis of NTRK1, the patient showed a clearly autosomal recessive inheritance pattern with the pathogenic mutation rs763758904 (Arg602*) and the second missense mutation rs80356677 (Asp674Tyr). Additionally, the genomic analysis showed 69 pathogenic and/or likely pathogenic variants in 46 genes possibly related to phenotypic heterogeneity, including the rs324420 variant in the FAAH gene. The gene ontology enrichment analysis showed 28 mutated genes involved in several biological processes. As a novel contribution, the protein-protein interaction network analysis showed that NTRK1, SPTBN2 and GRM6 interact with several proteins of the pain matrix involved in the response to stimulus and nervous system development. This is the first study that associates clinical, genomics and networking analyses in a Native American patient with consanguinity background in order to better understand CIPA pathogenesis.
机译:先天性对嗜睡(CIPA)疼痛的先天性内敏感性是一种极其稀有的常血剂质隐性障碍,其特征是对疼痛的不敏感,无法出汗和智力残疾。 CIPA是由神经营养酪氨酸激酶受体类型1基因(NTRK1)中的突变引起的,其编码神经生长因子(NGF)的高亲和力受体。在这里,我们在CIPA的一个9岁的女孩中呈现临床和分子结果。高空土着厄瓜多尔患者提出了几种健康问题,如缺血,骨折,自残,骨质粒细胞,智力残疾和里加联邦病。在NTRK1的突变分析之后,患者展示了具有致病性突变RS763758904(ARG602 *)和第二次畸形突变RS80356677(ASP674TY)的明显常血糖性隐性遗传模式。另外,基因组分析显示出46个基因中的69个病原和/或可能与表型异质性有关的致病性变体,包括FAAH基因中的RS324420变体。基因本体富集分析显示了若干生物过程中涉及的28个突变基因。作为一种新的贡献,蛋白质 - 蛋白质相互作用网络分析显示NTRK1,SPTBN2和GRM6与诸如刺激和神经系统发育的响应中涉及的疼痛基质的几种蛋白质相互作用。这是第一项研究,将临床,基因组学和网络分析与血缘关系背景相关联,以便更好地理解CIPA发病机制。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号